2024
DOI: 10.1007/s40261-023-01329-9
|View full text |Cite
|
Sign up to set email alerts
|

Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches

Jeffrey H. Lipton
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 88 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?